Jennifer Muhly
Family Medicine · Washington, PANPI 1750375168
Payments from drug & device makers
Across 164 payments — averaging $17.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$474
- AbbVie$370
- Pfizer$325
- Lilly USA, LLC$256
- Amgen$184
- GSK$146
- plus $1K from 28 others
What the payments were for
- Food & beverage$2,862100%
- Education$80%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 34 | $474 |
| AbbVie | 25 | $370 |
| Pfizer | 20 | $325 |
| Lilly USA, LLC | 15 | $256 |
| Amgen(2 entities) | 12 | $184 |
| GSK | 9 | $146 |
| Sanofi-aventis U.S. LLC | 2 | $107 |
| Exact Sciences | 4 | $95 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $91 |
| Medtronic(2 entities) | 3 | $67 |
| Astellas Pharma US Inc | 3 | $67 |
| Abbott | 4 | $59 |
| Aimmune Therapeutics, Inc. | 3 | $56 |
| Dexcom, Inc. | 3 | $49 |
| Novartis | 2 | $49 |
| Vanda Pharmaceuticals Inc. | 2 | $43 |
| Inspire Medical Systems, Inc. | 1 | $42 |
| AstraZeneca | 3 | $42 |
| Insulet Corporation | 2 | $39 |
| Merck | 2 | $34 |
| Vertex | 1 | $33 |
| Corcept Therapeutics | 1 | $26 |
| Edwards Lifesciences | 1 | $25 |
| Xeris Pharmaceuticals, Inc. | 1 | $23 |
| Johnson & Johnson | 1 | $19 |
| Alkermes, Inc. | 1 | $19 |
| Axonics, Inc. | 1 | $19 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $17 |
| Eisai Inc. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $17 |
| Baxter Healthcare | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Boehringer Ingelheim | 1 | $14 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
How this compares
$2,870 in reported general payments places this provider in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 351 | $226,617 |
| OzempicSemaglutide | 215 | $210,953 |
| TrulicityDulaglutide | 186 | $181,722 |
| JardianceEmpagliflozin | 139 | $132,373 |
| MounjaroTirzepatide | 63 | $73,283 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 109 | $71,731 |
| XareltoRivaroxaban | 80 | $59,787 |
| FarxigaDapagliflozin Propanediol | 70 | $47,613 |
| MyrbetriqMirabegron | 68 | $43,618 |
| LinzessLinaclotide | 49 | $35,563 |
| RybelsusSemaglutide | 23 | $35,429 |
| Spiriva RespimatTiotropium Bromide | 52 | $34,720 |
| ZenpepLipase/Protease/Amylase | 13 | $28,956 |
| Breo ElliptaFluticasone/Vilanterol | 48 | $28,419 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 52 | $26,919 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $256 | $255,005249 claims |
| Novo NordiskOzempic, Rybelsus | $474 | $246,382238 claims |
| PfizerEliquis | $325 | $226,617351 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $14 | $167,093191 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Incruse Ellipta | $146 | $116,856187 claims |
| Johnson & JohnsonXarelto | $19 | $59,78780 claims |
| AstraZenecaFarxiga | $42 | $47,61370 claims |
| Astellas Pharma US IncMyrbetriq | $67 | $43,61868 claims |
| AbbVieLinzess, Synthroid | $370 | $40,280127 claims |
| Aimmune Therapeutics, Inc.Zenpep | $56 | $28,95613 claims |
| NovartisEntresto | $49 | $4,71214 claims |
| MerckBelsomra | $34 | $4,41111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Washington
- Kem YenalPhila$12.6M
- Marcy FleckerSmithfield$6.9M
- Tiffany PlutoScottdale$4.8M
- Bryce PalchickPittsburgh$4.7M
- Harris CohenHorsham$3.7M
- Shari RozenPittsburgh$2.9M
- Richard CookUniontown$2.1M
- Bruce GebhardtErie$2.1M
- Peter CognettiScranton$1.9M
- Bradley FoxErie$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.